On December 18, 2025, the Holding Foreign Insiders Accountable Act (the Act) was enacted as part of the 2026 National Defense Authorization Act. Effective March 18, 2026, the Act eliminates an exemption from the reporting...more
1/21/2026
/ Beneficial Owner ,
Board of Directors ,
Corporate Officers ,
Directors ,
Disclosure Requirements ,
EDGAR ,
Filing Requirements ,
Foreign Private Issuers ,
Insider Trading ,
New Legislation ,
Publicly-Traded Companies ,
Regulatory Requirements ,
Reporting Requirements ,
Section 16 ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act of 1934 ,
Securities Regulation
In a marked departure from long-standing practice, the US Food and Drug Administration (FDA) has begun publishing stand-alone complete response letters (CRLs), formal communications that detail the deficiencies in a drug...more
During this session, the panelists shared alternative capital-raising financing strategies, including venture capital (VC), accelerators, spin-outs, bridge financing, licensing, and government agency support. They also...more
On April 12, 2024, the Supreme Court of the United States unanimously held in Macquarie Infrastructure Corp. v. Moab Partners, L.P. that pure omissions are not actionable under Rule 10b-5(b), promulgated by the US Securities...more
5/23/2024
/ Disclosure Requirements ,
Failure To Disclose ,
Macquarie Infrastructure Corp v Moab Partners LP ,
Omissions ,
Regulation S-K ,
Rule 10(b) ,
Rule 10b-5 ,
SCOTUS ,
Section 303 ,
Securities and Exchange Commission (SEC) ,
Securities Fraud ,
Securities Litigation ,
Securities Regulation ,
Securities Violations
There have been 44 initial public offerings (IPOs) listed on the US stock markets in 2024 thus far, many of which continue to trade at a premium to their initial offering price, demonstrating the strength and buoyancy of...more
4/16/2024
/ Acquisitions ,
Capital Markets ,
Disclosure Requirements ,
Dual Track Process ,
Initial Public Offering (IPO) ,
Interest Rates ,
Life Sciences ,
Mergers ,
Price Inflation ,
Private Equity ,
Securities and Exchange Commission (SEC) ,
Shareholders ,
Stock Prices ,
Valuation ,
Wages
On January 30, 2024, McDermott Partners Edward (Jed) Gordon, Kate Vera, and Todd Kornfeld and Associate Allison McSorley Tassel discussed on a panel the current market conditions and shared different capital raising options...more
2/12/2024
/ Acquisitions ,
Artificial Intelligence ,
Capital Raising ,
Corporate Governance ,
Cybersecurity ,
Domestic Dealmaking ,
Emerging Growth Companies ,
Executive Compensation ,
Incident Response Plans ,
Information Technology ,
Intellectual Property Protection ,
Machine Learning ,
Mergers ,
Recordkeeping Requirements ,
Startups
Please join McDermott for our highly anticipated Life Sciences Dealmaking Symposium! Now in its 12th year, the Symposium offers a unique platform for education, insight sharing, purposeful networking and strategic...more
10/23/2023
/ Acquisitions ,
Artificial Intelligence ,
Asset Valuations ,
Capital Markets ,
Capital Raising ,
Carve Out Provisions ,
Collaboration ,
Cross-Border Transactions ,
Events ,
Health Care Providers ,
Health Technology ,
Initial Public Offering (IPO) ,
Investors ,
IP License ,
IP Portfolio ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity Firms ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)